THE DEAL, AT A GLANCE
1/4 reviewedVumedi
01What it doesVumedi provides online educational content that helps clinicians learn about diseases, trials, and surgical techniques.Source-grounded · automated review · Explore ↗
02Who is involvedBacked by DrFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedVumedi raised $140M Series B, announced 2026-11-14From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersVumedi's $140M Series B is a large capital allocation within the database's Unclassified category, ranking at the 81th percentile of tracked rounds by size.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Vumedi · Financing Record
Explore source-linked visual explanations for Vumedi. Unsupported claims are withheld while source review continues.
Record 15996 · Recorded date: 2026-11-14
What it does
Vumedi is a video education platform for clinicians.
Source: vumedi.com ↗